The Global Human Genetics Market, estimated at US$ 23.12 Billion in the year 2020, is projected to reach a revised size of US$ 94.66 Billion by 2028, growing at a CAGR of 19.4% over the period 2021 to 2028.
Human Genetics: Introduction
The first-ever human genome/genetics project was accomplished in the year 2003, and It has cost around USD 3 Billion.
Understanding the complex nature of genes can aid in the creation of more effective treatment options and diagnostics for life-threatening illnesses, such as cancer AIDs, Alzheimer’s, sickle cell anemia, Parkinson’s as well as cystic fibrosis and Down syndrome and is further driving the growth of the market.
The prevalence of genetic disorders is growing in alarming proportions and is accelerating demands for genetic therapy. To address the issue, the R&D labs and forensic labs are conducting extensive research using human genetics to come up with new treatment options for a range of ailments.
Governments around the world are also assisting with the project and investing heavily into the market for human genetics to increase awareness of genetic diseases, their treatments, and the effects on our lives.
The first human genome-related project was completed in 2003 and cost about USD 3 billion.
Get free sample copy of this report:https://crediblemarkets.com/sample-request/human-genetics-market-840898
The Global Human Genetics Market Forecast
The use of human genetics research in targeted and precise medicines has led to the new world of Pharmacogenomics. It is the process of optimizing drugs to reduce adverse reactions to drugs. The rapid progress in personalized medicine will allow it to detect diseases before they occur and will allow medical professionals to identify them earlier and treat the condition according to the specific genetic profile of each patient.
The world’s governments are actively promoting the advances in human genetics to create a database that will hold a vast amount of medical and genetic information on the citizens of this country. In the past, CDC signed a cooperative agreement with three U.S. public health schools to provide public health personnel on the subject of genetics as well as its applications to health care.
Human genetics is currently only used in limited ways. But, it is predicted to see a significant increase in the coming years. Computational biology can provide an enormous space to store vast amounts of genetic data from various populations from all over the world. Furthermore, market players are likely to see significant growth in their revenue thanks to the rising amount of applications for human genetics to molecular diagnostic tests. For example, Myriad Genetics is expected to expand its reach following its breakthrough development of BRAC Analysis and BART tests for detecting genetic mutations that cause breast and ovarian cancers.
Beyond molecular tests as well as biometric identification for security checks will provide an opportunity to grow the market.
Market Drivers and Market Trends for the Global Human Genetics Market:
Market Drivers:
Rise In Number of Genetic Diseases Patients:
The growing prevalence of genetic disorders and improvements in genetic testing, as well as the growing use of the genetic test in oncology, are driving market expansion. According to the World Health Organization, some genetic diseases like sickle cell anemia afflicts about 72,000 babies, particularly those whose ancestors come from Africa. For instance, sickle-cell anemia is detected in one in every 500 African-American births and one in every thousand American births. In the same way, hemophilia, which is a genetic bleeding disorder, is a problem that affects 6,000 people in the U.K each year. The condition known as Cystic Fibrosis (CF) is yet another genetic disorder that impacts the respiratory, digestive, and reproductive organs. The condition is not well-known in Asia; however, it affects 1 out of 1,000 newborns in Europe.
Increasing Investment:
The successful conclusion of the Human Genome Project in 2003 by the U.S. Government created widespread economic impact around the world. Numerous major economies have invested substantial amounts of their revenues in human genetics. For instance, the U.K government has announced the ‘Genomics England project and invested about USD 250 million during 2018. The goal of the project is to help researchers identify uncommon and undiagnosed genetic conditions.
Raising Public Awareness:
Growing awareness and acceptance of genetics in humans are driving the market’s growth. In addition, the CDC is also trying to raise awareness about genetics among people. In the same way, the WHO has launched The Genetic Awareness Program to educate people about birth defects and genetic disorders. They also offer genetic consultation, chromosomal analyses as well as cytogenetic tests for similar.
Demand for Personalized and Precise Medicine Has Been Growing:
Over the last couple of years, personalizing medicine has witnessed a massive demand for diagnosis, prevention, and treatment of various diseases. It removes the chance of allergies and adverse reactions associated with the medications. The advancements in genetic testing and the increasing use of oncology genetic testing will likely boost the market’s growth to some degree.
Latest Trends:
The enormous potential offered by the genome sequencing process has led to the growth of startups over the last few years. Numerous companies have begun offering services to sequence genomes for a range of applications, such as diet, ancestry and nutrition, and genetic diseases, among other things. 23andMe is one such company that has experienced significant growth. The increase in funding for a new company is likely to encourage growth in the market. In July, for instance, 2020, Genome Medical, a startup offering the telehealth of genetic consultations, has raised the sum of US$ 14 million extensions to their US$ 33 million Series B round. The company plans to use the money to increase its telehealth platform as well as clinical operations. The first step is a meeting to determine if the person might be benefited from genetic tests and which tests are most appropriate for the individual.
The Key Market Segmentation of the Global Human Genetics Market:
Global Human Genetics Market can be divided into Types, End-User, Technology, Application, and Geographical landscapes, etc.
Human Genetics Market Segmentation By Key players:
- QIAGEN
- Agilent Technologies
- Thermo Fisher Scientific
- Illumina
- Promega
- LabCorp
- GE
Human Genetics Market Segmentation By Type:
- Cytogenetics
- Prenatal Genetics
- Molecular Genetics
- Symptom Genetics
Human Genetics Market Segmentation By End-User:
- Research Center
- Hospital
- Forensic Laboratories
Human Genetics Market Segmentation By Technology:
- Polymerase Chain Reaction (PCR)
- Next-generation Sequencing (NGS)
- Microarray
- Sanger Sequencing
- Others
Human Genetics Market Segmentation By Application:
- Diagnostics
- Research
- Others
Human Genetics Market Segmentation By Geographical Landscape:
- North America
- Europe
- Asia Pacific
- South America
- The Middle East and Africa
Get more information related to this report@ https://crediblemarkets.com/market-analysis/human-genetics-market-840898
About Credible Markets:
Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.
